For a few years Archer has already been simultaneously developing the bio-chip alongside the 12CQ quantum chip.
From the website: ”We are developing a potential solution to rapid multiplexing that involves lab-on-chip biosensors that could simplify medical diagnosis and aid point of care disease management.”
Check out the developments from 2018. Fabrication commenced this year in April. And last week it was the bio chip US patent progress that excited the market boosting the share price over $3.
The same week the AFR suspiciously confused the two technologies and appeared to intentionally attempt to discredit Archer. A bit of misdirection/slight of hand perhaps?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)